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A set of pancreatic stones and surgical specimens with chronic pancreatitis from various
etiologies has been investigated by mFourier Transform Infra-Red spectroscopy and ﬁeld
emission scanning electron microscopy in order to gather information regarding their
chemical composition and their structural characteristics at the mesoscopic scale. These
physicochemical data were compared to the medical data of the patients. Regarding the
pancreatic stones, the complete set of data underlines the presence of three calcium
carbonate polymorphs as well as a great diversity on their spatial distribution (core
versus surface), a wide range of protein content and the presence of other phases in a
limited number of samples. These results suggest that very different mechanisms are
involved in stone formation. The results have been also obtained on pancreas tissues.
Chemical diversity also exists for ectopic calciﬁcations. The presence of CA and its
amorphous precursor (ACCP) constitutes a real challenge for clinicians, such chemical
compounds being associated with biological parameters far from those related to calcium
carbonate.
© 2015 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As underlined by Rosenkranz and Patel [1], stones in
biliary and pancreatic ducts constitute pathological calci-
ﬁcations [2e4] that plague hundreds of thousands of, Department of Pa-
ed by Elsevier Masson SAS.patients worldwide every year with symptoms that can be
mild (pain) to life threatening (cholangitis, severe acute
pancreatitis). This major public health problem has moti-
vated several investigations at the interface between
physics, chemistry, and medicine in order to describe at the
multiscale the structural and chemical characteristics of
such biological entities [4e17]. While obstruction of
pancreatic ducts by gallstones is the most common cause
for acute pancreatitis, calcium salt deposition within theThis is an open access article under the CC BY-NC-ND license (http://
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pathological conditions. The ultimate aim of the studies is
to relate the stone chemistry and structural parameters to
pathology in order to better understand the pathogenesis
and thus delineate the process of pancreatic stone forma-
tion. Such a relationship exists for other pathological cal-
ciﬁcations such as kidney stones [18e20] and has been
assessed for calciﬁcations present in prostate [21,22], breast
[23] and cartilage [24e28].
Several investigations have been performed in order to
shed light on the chemistry of pancreatic calculi [4e17].
Their chemical analyses by X-ray scattering have shown
that most of them contain calcium carbonate (CaCO3)
such as calcite [29], vaterite [30], and aragonite [31]. The
presence of these calcium carbonate polymorphs is due to
the composition of pancreatic secretion for which the ﬁrst
component is a solution of bicarbonate, Naþ, Kþ and
water emitted by the epithelial cells that line the
pancreatic ducts. The high level of bicarbonate as well as
high values of pH of this alkaline solution explain the
presence of calcium carbonates [6]. Other chemical pha-
ses such as brushite [7] and Ca phosphate compounds
[10] have also been identiﬁed. Finally, protein deposits
also exist [8,32].
Pancreatic calciﬁcations are mostly seen in advanced
stages of chronic pancreatitis. There are many etiologies
and some, such as speciﬁc forms of hereditary pancrea-
titis, are associated with an increased risk of pancreatic
cancer. Hereditary pancreatitis represents a peculiar form
of chronic pancreatitis in which several genes involved in
the trypsinogen pathway have been identiﬁed [33].
Although they are usually diagnosed earlier than toxic
chronic pancreatitis (alcohol related for instance), there is
no speciﬁc clinical sign and fastidious sequencing of
multiple genes is required when the diagnosis is sus-
pected. PRSS1, SPINK1, and CFTR to some extent are the
most frequently mutated genes in hereditary pancreatitis
[34]. The PRSS1 gene encodes the cationic trypsinogen that
represents 2/3 of the total trypsinogen in the pancreatic
juice. Trypsinogen is an inactive precursor of trypsin with
capacities of activation and autodigestion. This autodi-
gestion is linked to a particular proteolytic site of the
protein in the R122 position. This primary proteolytic site
can become resistant in the case of mutations such as the
most described R122H [35]. Other reported mutations
(>30 described in 2012) can increase the autocatalytic
conversion of trypsinogen to active trypsin explaining
recurrent acute pancreatitis by intrapancreatic trypsin-
ogen activation. The natural inhibitor of trypsinogen
SPINK1 (serine protease inhibitor Kazal type 1) is secreted
by the pancreatic acinar cells and can inhibit around 20%
of the intrapancreatic trypsin activity. Inactivating muta-
tion may therefore result in trypsin overactivity-related
pancreatitis. Several studies demonstrated an association
between a SPINK1 mutation (N34S) and chronic pancre-
atitis, although it is not yet clear how it affects SPINK1
activity ([36] and reviewed in [37]). For CFTR, the mech-
anism is slightly different. Mutations impairing this
transporter function are responsible for a decrease in
pancreatic juice bicarbonate concentration resulting in
intracanalar protein plugs and calciﬁcations.In this investigation, pancreas stones and surgical tissue
specimens from patients suffering from chronic pancrea-
titis of various etiologies were investigated in order to
assess their physicochemical characteristics and compare
them with the clinical data of the patients. Among the
different techniques which can obtain signiﬁcant infor-
mation on pathological calciﬁcations [38e40], we com-
bined mFTIR spectroscopy [41] and ﬁeld emission scanning
electron microscopy [42] to describe structural character-
istics and chemical composition at the micrometer scale.
This new class of structural characterization techniques
clearly opens a land of opportunities for the understanding
of the biochemical parameters that drive the pathogenesis
of ectopic calciﬁcations [2e4].
2. Materials and methods
A set of 14 pancreatic stones (Tenon Hospital, Paris,
France) without clinical annotation and of 12 surgical
specimens of pancreas tissue (Beaujon Hospital, Clichy,
France) from patients with chronic pancreatitis were
investigated. In the later cohort, the calciﬁcations were
microscopic (<5 mm). They were mostly located within
small pancreatic ducts or embedded within the pancreatic
tissue. There was no common patient between the two
cohorts.
Pancreatic stones were analyzed sequentially from the
core to the surface by means of selective samples picked
up under a stereomicroscope. Then, the samples were
mixed with potassium bromide to obtain pellets as pre-
viously described in Ref. [43]. The molecular and crys-
talline composition was determined by infrared
spectroscopy using the transmission mode in the wave-
length range of 2.5e25 mm (4000e400 cm1) with a
4 cm1 resolution.
Five micrometer-thick slices of the tissue samples were
deposited on low-e microscope slides (MirrIR, Kevley
Technologies, Tienta Sciences, Indianapolis). For tissue
embedded in parafﬁn, the parafﬁnwas chemically removed
by xylene baths in order to improve the crystal detection
under the microscope. Each sample was only named by a
study number, without indication of the name of the pa-
tient or potential identiﬁcation data.
A Zeiss SUPRA55-VP SEM was used for the observation
of microstructures. This ﬁeld-emission gun microscope
(FE-SEM) operates at 0.5e30 kV. High-resolution obser-
vations were obtained by using two secondary electron
detectors: an in-lens SE detector and an Everharte
Thornley SE detector. To maintain the integrity of the
samples, measurements were taken at low voltage (be-
tween 0.5 and 2 kV) without the usual deposits of carbon
at the surface of the sample (Fig. 1a). Energy Dispersive X-
ray (EDX) spectrometry analyses were also performed. In
order to perform Ca cartography, the FE-SEM is operated
at 12 kV.
IR microspectroscopy was also performed on an
IN10MXmicroscope (Thermo Scientiﬁc) for recording large
maps. All spectra were collected in ultrafast mode using a
50 mm  50 mm aperture. The spectra were collected in the
4000e800 cm1 mid-IR range at a resolution of 16 cm1
with one spectrum per pixel. Data analysis of IR spectra and
Fig. 1. Abundance of polymorphs as a function of temperature (adapted
from Ogino et al. [60]).
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(Thermo Scientiﬁc).
3. Results
In Table 1 the results of stone composition as deter-
mined by infrared spectroscopy are summarized. Anhy-
drous calcium carbonate was the main chemical species in
all cases in the form of one or several among the threeTable 1
Chemical composition of pancreatic stones as given by FTIR spectroscopy. Inform
Sample Sex, age (years) Chemical composition as given by
242 H Core and surface: calcite (99%) þ
575 F, 26 Core: proteins; surface: calcite[
average composition: calcite (50%
pathology: inherited calcifying pa
5745 F, 71 Core: calcite[ aragonite[ pro
average composition: aragonite (8
8959 H, 43 Core: calcium palmitate\ prote
average composition: calcite (85%
9464 H, 55 Core and surface: calcite (99%), pr
16232 F, 40 Core: calcite (100%); surface: arag
average composition: aragonite (6
16568 H, 62 Core and surface: calcite (90%), pr
32274 F, 37 Core: proteins; surface: calcite[
average composition: calcite (66%
pathology : inherited calcifying pa
33043 H, 49 Core: calcite\ proteins; surface
average composition: calcite (70%
pathology: alcohol-related chroni
43580 H, 63 Core: calcite[ aragonite; surface
average composition: calcite (60%
48440 H, 17 Core: calcite[ vaterite; surface:
average composition: calcite (70%
59791 H, 41 Core and surface: calcite[ prote
average composition: calcite (90%
59849 H, 66 Core: calcite[ proteins; surface:
average composition: calcite (75%
pathology: alcohol-related chroni
67483 H, 43 Core: calcite[ proteins; surface:
average composition: calcite (85%polymorphs. Calcite was found in all stones while aragonite
was identiﬁed in 8/14 samples (57.1%) and vaterite in only
three calculi (21.4%). Other calcium salts were identiﬁed as
minor components such as carbapatite in two cases (14.3%)
and calcium palmitate in one case (7.1%). The calcium
phosphate content was very low (5%). By contrast, the
protein content was very variable, ranging from about 1%
up to 30%. Of note, the highest content of proteins was
found in patients presenting with inherited calcifying
pancreatitis. In such cases, the stone core was made of
proteins while in other pathological conditions it was made
of a calcium salt. In one case, the core was predominantly
made of calcium palmitate, which suggests a high content
of free fatty acids in the pancreatic juice.
In Table 2 the available data regarding pancreatic tissue
samples analyzed by infrared microspectroscopy are
gathered.
By contrast with pancreatic stones, only two poly-
morphs of anhydrous calcium carbonate were detected in
pancreatic calciﬁcations, i.e., calcite and vaterite. Calcium
orthophosphate as apatite was identiﬁed in only one case,
in association with amorphous carbonated calcium phos-
phate. Of note, calcium carbonate was not detected in this
sample.4. Discussion
The pancreas acts as an exocrine gland (by producing
pancreatic juice which empties into the small intestine via
the main pancreatic duct) and an endocrine gland (by
producing several hormones including insulin). Pancreatication regarding the associated pathology is also given when available.
FTIR spectroscopy
traces of CA and proteins
proteins[ aragonite
), proteins (30%), and aragonite (20%)
ncreatitis
teins; surface: aragonite[ proteins
0%), calcite (15%), and proteins (5%)
ins; surface: calcite\ proteins
), proteins (8%), and calcium palmitate (7%)
oteins (1%)
onite[ proteins and calcite
7%), proteins (13%), calcite (8%), triglycerides (7%), and carbapatite (5%)
oteins (10%)
proteins, aragonite
), proteins (20%), aragonite (14%)
ncreatitis
: calcite[ aragonite[ proteins
), aragonite (15%), proteins (10%), and vaterite (5%)
c pancreatitis
: calcite[ aragonite[ proteins[ vaterite
), aragonite (20%), proteins (10%), and vaterite (10%)
calcite[ aragonite, proteins and vaterite
), proteins (15%), aragonite (10%), and vaterite (5%)
ins
), proteins (10%)
calcite[ aragonite[ proteins
), aragonite (15%), and proteins (10%)
c pancreatitis
calcite[ vaterite and proteins
), proteins (10%), and vaterite (5%)
Table 2
Physiological and clinical data of the patients and chemical composition of the corresponding tissue samples. (CP: chronic pancreatitis, ACP: alcohol related
chronic pancreatitis, IPMN: intraductal papillary and mucinous neoplasm, and ACCP: amorphous carbonated calcium phosphate).
Samples Age Disease Chemical composition of pathological
deposits through FTIR spectroscopy
Sample 1 e B0408022_P3_A 36 IPMN w/CP Glycated proteins
Sample 2 e B0353568_R 36 ACP Calcite
Sample 3 e B0505143 51 CFTR þ SPINK1 CP Calcite þ traces of CA and ACCP
Sample 4 e B0322978 38 Unknown Vaterite (744 cm1 & 1085 cm1)
Sample 5 e B0448146 31 PRSS1 CP Vaterite þ calcite
Sample 6 e B0515722 (same patient as for sample 3) 52 CFTR þ SPINK1 CP Calcite and trace of CA and ACCP
Sample 7 e B0298452_5C 37 Unknown Calcite
Sample 8 e B0517376_18 50 PRSS1 CP Calcite þ vaterite
Sample 9 e B0410070_11 49 Unknown Calcite þ vaterite
Sample 10 e 13AG03778_03 48 Cystic ﬁbrosis ACCP
Sample 11 e 13AG03478 08 71 Unknown Apatite þ ACCP
Sample 12 e 13AG03685_05 52 ACP Calcite þ vaterite
J. Cros et al. / C. R. Chimie 19 (2016) 1642e1655 1645secretion is an alkaline liquid, which contains a variety of
enzymes. Pancreatic secretion contains bicarbonate, Naþ,
Kþ and water emitted by the epithelial cells that line the
pancreatic ducts. Such alkaline solution neutralizes stom-
ach acid so that digestive enzymes work more effectively.
This secretion contains also several enzymatic components
such as trypsinogen and chymotrypsinogen… In line with
its chemical properties (a high level of bicarbonate as well
as high values of pH), pancreatic secretion leads to the
formation of calcium carbonate.
CaCO3 has a pivotal role in biomineralisation processes
in a number of animal species andmicroorganisms, but it is
infrequent in humans with the exception of physiological
crystals in the inner ear and pathological calciﬁcations in
pancreas and gallbladder. Such biominerals are one of the
most common types present in mollusc shells or pearls,
eggshells, and corals [44e46] and cyanobacteria [47]. The
literature on calcium carbonate is thus quite vast [see for
example Refs. 44e56], this system being one of the most
widely studied precipitation systems. Most of the studies
try to understand their functions which depend on their
shape, size, abundance, position versus the biological tis-
sue, and chemical composition. The prominent hallmark of
biomineralization is the morphological control during
mineral crystallization. In the case of pathological calciﬁ-
cations, the chemical composition as well as the crystal
morphology are also two key parameters to establish a
signiﬁcant link with the disease [18,57e63] and has moti-
vated this investigation by SEM and mFTIR spectroscopy.
Different species of calcium carbonate exist. Starting
with the most stable one, we have the anhydrous species
(CaCO3) namely calcite, aragonite, and vaterite, the hy-
drated species such as monohydrocalcite (CaCO3$H2O) or
Ikaite (CaCO3$6H2O) and ﬁnally the amorphous one CaCO3
whichmay containwatermolecules [64,65]. Note that Levi-
Kalisman et al. [66] have underlined that several kinds of
amorphous carbonate exist, their stability depending on
the presence of other compounds such as phosphates.
Moreover, J. Ihli et al. [67] showed that amorphous calcium
carbonate can dehydrate before crystallizing, both in so-
lution and in air. One of the striking points of this investi-
gation is related to the fact that the loss of the ﬁnal water
fraction e comprising less than 15% of the total e triggers
crystallization. Finally, in the case of pathologicalcalciﬁcations, it can be interesting to consider the publi-
cation of Ogino et al. [68], which have assessed the abun-
dance of polymorphs as a function of temperature as
illustrated in Fig. 1.
The space group of the most stable species, i.e. calcite, is
R3c with a ¼ 6361 Å and a ¼ 4660 [69e71]. In fact, in the
crystal nucleation stage, calcite is the most stable form
while aragonite becomes more stable when the crystal is
large enough for the bulk lattice energy to outweigh the
surface energy terms [72]. Calcite crystals display rhom-
bohedra with a square, a morphology in line with their
crystallographic structure [73]. Other possibilities (twin
crystals) have been considered. Morphologies of calcite
crystals can be controlled by impurities [74] such as Mg
[75] or peptides [76]. In the case of aragonite, the space
group is Pmcn with a ¼ 4.94 Å, b ¼ 7.94 Å and c ¼ 5.72 Å,
while for the vaterite the system is hexagonal (a ¼ 4.12 Å,
c ¼ 8.556 Å) [29,37]. In fact, using aberration-corrected
high-resolution transmission electron microscopy, L.
Kabalah-Amitai et al. [30] found that vaterite is actually
composed of at least two different crystallographic struc-
tures that coexist within a pseudo-single crystal. Regarding
amorphous calcium carbonate, Breýeviû and Nielsen [77]
isolated ACC by freeze drying and found the powder con-
sisting of spherical particles with diameters in the order of
50e400 nm. Note that complex calcium carbonate entities
can be obtained. For example, S.S. Wang et al. [78] have
obtained calcium carbonate microspheres with calcite
equatorial loops and vaterite spherical cores.
4.1. Pancreatic stones
At the macroscopic scale, pancreatic stones are associ-
ated with different morphologies. In Fig. 2, three pancreatic
stones are visualized. While the ﬁrst one (Fig. 2a) is
constituted to an agglomeration of rod shaped entities
resembling corals, the two other stones (Fig. 2b,c) have a
round shape and exhibit a calcite cockle with a core of
protein.
A set of SEM micrographs of pancreatic stones at the
micrometer scale shows very different structures. In
Fig. 3a,b, sharp acicular entities are visible in contrast to
very smooth entities that seem to be embedded in an
organic ﬁlm (Fig. 3cee) or in contact with tissue or cells
Fig. 2. Pancreatic calculi. At the macroscopic scale, different morphologies exist (agglomeration of rod shaped entities (a) or round shape with a calcite cockle and
a protein core (b and c).
J. Cros et al. / C. R. Chimie 19 (2016) 1642e16551646(Fig. 3f). Such organic part may be constituted by lith-
ostathine, a protein that was initially considered as an in-
hibitor of calcium carbonate crystal growth in pancreas
ducts where the supersaturation is common for that
chemical species [79e82]. However, more recent studies
suggest that lithostathine could act as a non-speciﬁc in-
hibitor similarly to other proteins such as albumin [83]. In
patients suffering from familial calcifying pancreatitis,
mutations of the gene involved in lithostathine synthesis
are responsible for tissue calciﬁcation either because of a
quantitative defect in lithostathine production or, as
observed in Fig. 2b,c, by production of partly or entirely
inactive mutated proteins that are able to precipitate in the
pancreas, serving as a template for further calcium car-
bonate deposition. Such a mechanism may thus favor the
formation of pancreatic stones that may obstruct the main
duct and induce acute and/or chronic pancreatitis. Of note,
an analog of lithostathine was also identiﬁed in the kidney
tissue, where, by an adsorption process on the crystal sur-
face, it could protect against the potential heterogeneous
nucleation of weddellite on calcite crystals [84]. Finally,
observations of crystallites with smooth surfaces have been
already done in the case of cystine kidney stones in patients
treated by alkali or/and thiol therapy [85].
SEM observations offer an opportunity to describe the
complex biochemical parameters which drive the growing
mechanisms of pancreatic stones. H. Harada et al. [6] have
noticed that crystalline calcite showed spiral and epitaxial
growth along with ﬁndings of dissolution, resembling
cholesterol crystals of gallstones. These authors supposed
that pancreatic stones were probably formed through
central core formation and layered growth of a shell. A.C.Schultz et al. [11] underline that a central amorphous ma-
terial was observed in 30% of the pancreatic stones indi-
cating that the protein present at the core of the pancreatic
stones constitutes a nucleus for pancreatic stones, an hy-
pothesis already proposed by H. Sarles et al. [5] in patients
with alcoholic pancreatitis.
Regarding a possible link between pancreatic stones and
diseases, pancreatic calciﬁcations have long been consid-
ered speciﬁc for chronic pancreatitis [86,87]. In a recent
study, A. Campisi et al. [88] have shown that pancreatic
calciﬁcations are observed in awide spectrum of pancreatic
diseases. These authors underline the fact that certain
ﬁndings (parenchymal calciﬁcations, diffuse distribution,
intraductal calciﬁcations, parenchymal atrophy, and cystic
lesions) are noted more often in chronic pancreatitis than
in other pancreatic diseases harboring calciﬁcations. Un-
fortunately, this investigation was based only on cardinal
computed tomography and it was thus quite difﬁcult to
discuss the chemical composition of the pancreatic
calciﬁcations.
In our study, FTIR spectroscopy points out the pres-
ence of these calcium carbonate polymorphs as well as a
great diversity on the spatial distribution of these three
calcium carbonates in the core and at the surface of the
pancreatic stones. Due to the low number of samples, it is
quite difﬁcult to extract a link with disease from these
structural data. However, our results suggest that
different mechanisms are involved in stone formation. For
example, in inherited calcifying pancreatitis, the protein
content of the stones was especially high and the core, by
contrast to other pathological conditions, was mainly
composed of protein agglomerates. In another case, the
Fig. 3. Different morphologies observed in pancreatic stones. (a) and (b) Large acicular entities with well-deﬁned edges and faces; (c), (d), and (e) structures with
smooth edges and numerous surface defaults, some have a circular shape probably due to the presence of tissues or cells; (f), (g), and (h) well-deﬁned structures
observed in tiny calcite crystals at the micrometer scale.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e1655 1647core of the stone was made of a fatty acid, crystallized as
calcium salt, which appears to be a very uncommon
condition. Unfortunately, we have no clinical data for this
patient.Table 3
Infrared frequencies of calcite, aragonite and vaterite according to C.E. Weir and
n1 n2
Calcite 1087 cm1 (weak) 881 cm1
Aragonite 1087 cm1 866 cm1
Vaterite 1090 cm1 850 & 878 cm4.2. Surgical specimens with chronic pancreatitis
Regarding mFTIR spectroscopy, since the pioneering
work of T.B. Morse [89], mid-Infrared absorption bands ofE.R. Lippincott [91].
n3 n4
1432 cm1 712 cm1
1430 & 1550 cm1 703 & 715 cm1
1 1450 cm1 711 & 747 cm1
J. Cros et al. / C. R. Chimie 19 (2016) 1642e16551648calcium carbonate have been extensively studied [90e97].
From a fundamental point of view, isolated planar ion XO3
displaying a trigonal symmetry has four fundamental
modes of vibration, the symmetric stretching, n1, the out ofFig. 4. Sample 5: (a) typical IR absorption bands of the calcite calciﬁcation; 0 corr
while 1,2, and 3 are related respectively to the combination band, n3 and n2 IR absorp
different contributions coming from have been indicated; (c) generally the IR spec
calcite) and tissues; (d) classical analysis of FTIR data is to compare the spatial distri
optical photography. Of note, the red cross in (d) and (e) indicates where the IR spplane bending, n2, the doubly degenerate antisymmetric
stretching, n3, and the doubly degenerate planar bending,
n4. In a crystalline solid containing more than 1 molecule
per unit cell, symmetry considerations indicate that allesponds to the residual absorption of CO2 present in the room experiments
tion bands of calcite; (b) IR absorption bands of a biological tissue where the
trum contains contributions coming from both calciﬁcations (here made of
bution of a chemical compound selected by an IR absorption band and (e) the
ectrum has been collected.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e1655 1649modes may be active. Following the investigations by C.E.
Weir and E.R. Lippincott [91], these four fundamental
modes are represented in Table 3 for the different poly-
morphs of CaCO3.
These calculated values are close to the ones measured
for the different compounds. These characteristic bands of
calcite are observed at 712 cm1 (n4; in-plane bending) and
875 cm1 (n2: OeCeO out-of-plane bending) while the n1
symmetric stretching band at 1086 cm1 is inactive in the
IR mode (active in the Raman mode) [41,98,99]. For
aragonite (resp. vaterite), absorption bands are, respec-
tively, 699 and 713, 854, and 1082 cm1 (resp. 713 and 744,
876, and 1086 cm1) [41,91,95]. As underlined by N.V.
Vagenas et al. [96], the positions of the wavenumbers are
unique for each carbonate mineral and are thus diagnostic
of their mineralogy. Note that the combination band near
1800 cm1 (1799 cm1 for calcite and 1788 cm1 for
aragonite) is composed of contributions from combination
of the n3 asymmetric stretching and the n6 and n8 external
modes of the carbonate groups and Ca2þ ions [100e102].
In Fig. 4, typical FTIR spectra corresponding to the
calciﬁcation (4a), to the tissue (4b) or to a mixing of calci-
ﬁcation and tissue (4c) are presented. Here, the calciﬁcation
is made of calcite and we can identify quite easily its three
IR absorption bands (1799e1390e875 cm1) versus vater-
ite (1403e1085e744 cm1).
In Fig. 4b, the IR spectrum shows the presence of the
major molecular species, amide I and II from the protein
constituents of the pancreatic tissue [103e107]. The amideFig. 5. Sample 8: (a) typical IR absorption bands of the calcite calciﬁcation recorde
ectopic calciﬁcation as measured through the intensity of the IR absorption band afunctional group combines the features of amines and ke-
tones because it has both the NeH and the C]O bonds. In
ketones, carbonyl compounds (those that contain the C]O
functional group) are in the middle of the carbon chain
while in aldehydes, this group is at the end. The most
characteristic band in amines appears as a weak to medium
IR broad band in the range of about 3200e3600 cm1 and is
due to the NeH bond stretching. More precisely, two NeH
stretching peaks may be observed, one near 3350 cm1 and
one near 3180 cm1, from asymmetric and symmetric vi-
brations, respectively.
In biological tissues, the bands at 1640 cme1 and
1546 cme1 correspond to amide I C]O stretchingmode and
amide II NeH bending and CeN stretching in proteins. As
underlined by L.MMiller and P. Dumas [108], the vibrational
frequency of the amide I (C]O) band can be signiﬁcantly
affected by different hydrogen-bonding environments for
a-helix,b-sheet, turn, andunordered structures. In this case,
it is possible to deconvolute the absorption bands in
different contributions. Other data analysis processes are
possible [109e112]. Correlation factors can be calculated in
order to perform the correlation analysis. Finally, principal
component analysis can also be used to extract relevant
information from the spectral dataset.
In Fig. 4c, both contributions coming from the tissue and
the calciﬁcation are visible. It is the case when the size of
the calciﬁcation is less than the size of the beam (here a few
microns). Finally, from the FTIR data it is possible to obtain
quite simply the spatial distribution of the differentd at the level of the red cross in Fig. 5c; (b) Spatial repartition of the calcite
t 875 cm1; (c) Optical map at the same scale.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e16551650molecular species that have been identiﬁed through their
IR absorption bands. In order to obtain the spatial distri-
bution of calcite (Fig. 4d), its absorption band has been
selected (in that part of the IR spectra, only contribution
coming from calcite is present). For the clinician, it is
possible to localize precisely the calciﬁcation in the tissue
through a comparison with the optical map (Fig. 4e).Fig. 6. Sample 9: (a) typical IR absorption bands of the calcite calciﬁcation; (b)
supplementary peak at 1085 cm1; (c) typical IR absorption bands of a calciﬁcatioEven in the case of large calciﬁcations (Fig. 5), it is
possible to perform such analysis. For sample 8, informa-
tion regarding the localization of large calciﬁcations (larger
than 1 mm) can be obtained.
For sample 9, which corresponds to an unidentiﬁed
etiology, two calcium carbonate polymorphs have been
identiﬁed. Thanks to the high sensitivity of FTIRthe presence of small proportions of vaterite induced the observation of a
n made of vaterite.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e1655 1651spectroscopy, it is possible to distinguish between calcite
(Fig. 6a) and vaterite (Fig. 6c). When the two polymorphs
are present, the IR spectrum is simply a combination of the
two IR spectra (Fig. 6b).
For sample 10, which corresponds to a patient with
cystic ﬁbrosis, a precise observation of the IR absorption
spectra underlines (arrows) the possible presence of
different chemical phases in addition to proteins such as
silicate (contamination?) (Fig. 7a), mucopolysaccharides,
without (Fig. 7b) and with small amounts of calcium
phosphate (Fig. 7c), or Ca phosphate apatite alone
(Fig. 7d).
It is also possible to gather information regarding the
morphology of the ectopic calciﬁcation after its chemical
identiﬁcation through FTIR spectroscopy. For sample 3
coming from a patient with chronic pancreatitis (Fig. 8), FE-Fig. 7. Sample 10: the IR spectrum seems to show, in addition to proteins, the pres
calcium phosphate (low content) (c), and of Ca phosphate apatite (d).SEM observations have been performed after the acquisi-
tion of a FTIR map on the very same sample. In that case,
details at the micrometer scale can be obtained. As we can
see, the faces of calcite crystallites are not well deﬁned
suggesting that we have at the micrometer scale a mixing
between mineral and proteins.
Finally, in another sample of pancreatic tissue, FTIR ex-
periments underlined the presence of ectopic calciﬁcations
made of Ca phosphate apatite. A careful examination of the
IR absorption at 1030 cm1 indicates the presence of Ca
phosphate apatite and amorphous Ca phosphate apatite.
Also, this Ca phosphate apatite is carbonated as indicated
by the presence of carbonate IR absorption bands (Fig. 9).
Etiologies of chronic calcifying pancreatitis are
numerous and may sometimes be combined. A robust tool
to help deﬁne the etiology would be greatly appreciated,ence of silicate (a), of mucopolysaccharides (b), of mucopolysaccharides and
Fig. 8. Set of data collected for sample 3: (a) optical microscope observation; (b) typical infra red spectrum; (c) spatial distribution of calcite corresponding to the
spatial distribution of the intensity of the IR absorption bands at 875 cm1; (d) topology of the very sample is obtained through SEM; (e) details of the sample
surface visualized at higher magniﬁcation.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e16551652especially in cases of hereditary pancreatitis in which
multiple gene sequencing is long and expensive. Chronic
pancreatitis is often managed medically. Surgical speci-
mens are rare resulting in a very small number of patients
for a given etiology. It did not seem that one type of calci-
ﬁcation composition was restricted to one etiology but
larger groups are necessary to deﬁnitively conclude. Closerelationships have been observed between pancreatic cal-
ciﬁcations and the metabolism of calcium. It was reported
that chronic pancreatitis is a possible cause of hypocalce-
mia. By contrast, hypercalcemic states of primary hyper-
parathyroidism may induce pancreatic calciﬁcations
[113e114]. Calcium phosphate deposits were found in
human pancreatic adenocarcinoma (Capan-1) cell cultures
Fig. 9. Sample 11. (a) Optical microscope observations; (b) spatial distribution of the apatite in the sample; (c) IR absorption spectrum pointing out the presence
of microcalciﬁcations made of highly carbonated apatite. Note the presence of ACCP through the attenuated shoulder (around 1100 cm1) of the n3 absorption
band of apatite at 1030 cm1.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e1655 1653[115]. Low citrate concentration, high calcium diffusion
from interstitium to pancreatic juice, local protein precip-
itation and other alterations in the pancreatic juice
composition are possible factors involved in pancreatic
calciﬁcations [109]. We can expect differences in the
chemical form, crystalline phases, accurate distribution and
abundance of calciﬁcations according to the etiology. Our
results suggest that further investigations should be per-
formed to relate more precisely pancreatic calciﬁcationsand the etiology of pancreatitis, as demonstrated for other
tissues such as kidney [18e20].
5. Conclusion
Even if stones in biliary and pancreatic ducts constitute
a major public health problem, the number of in-
vestigations based on physical techniques remains quite
limited. Our investigation clearly shows that only
J. Cros et al. / C. R. Chimie 19 (2016) 1642e16551654techniques such as last generation FTIR and FE-SEM
experimental devices offer a chemical and structural
description at the mesoscopic scale and are able to bring to
clinicians a signiﬁcant description of pathological calciﬁ-
cations [2e4].
Regarding the pancreatic stones, FTIR spectroscopy and
FE-SEM observations underline the presence of the three
calcium carbonate polymorphs as well as a great diversity
on their spatial distribution (core versus surface). These
results suggest that very differentmechanisms are involved
in stone formation. For example, in inherited calcifying
pancreatitis, the protein content of the stones was espe-
cially high and the core, by contrast to other pathological
conditions, was mainly composed of protein agglomerates.
In another case, the core of the stone was made of a fatty
acid, crystallized as calcium salt, which appears to be a very
uncommon condition.
Major results have been also obtained on pancreas tis-
sues. Chemical diversity exists also for ectopic calciﬁca-
tions. The presence of CA and its amorphous precursor
(ACCP) constitutes a real challenge for clinicians, such
chemical compounds being associated with biological pa-
rameters far from those related to calcium carbonate.
Due to the limited number of samples in this investi-
gation, it was not possible to establish a possible relation-
ship between the calciﬁcations' composition and the
chronic pancreatitis etiology. These pathologies are rare
and the small number of subjects may have masked rele-
vant associations. However, the chemical diversity of cal-
cium deposits (carbonate or phosphate) suggests a variety
of pathological conditions involved in pancreatic calciﬁca-
tions. The precise crystalline form of calcium carbonate or
calcium phosphate identiﬁed in the tissue could be simply a
marker of the timing of the calciﬁcation process regardless
of the causing mechanism. Studies are in progress to better
understand the actual relationships between crystals and
pathology as performed in other tissues.
Acknowledgments
This work was supported by the Physics and Chemistry
Institutes of CNRS and by contracts ANR-09-BLAN-0120-02,
ANR-12-BS08-0022, ANR-13-JSV-10010-01, convergence
UPMC CVG1205 and CORDDIM-2013-COD130042.
References
[1] L. Rosenkranz, S.N. Patel, Gastrointest. Endosc. Clin. N. Am. 22
(2012) 435.
[2] D. Bazin, M. Daudon, C. Combes, C. Rey, Chem. Rev. 112 (2012)
5092.
[3] D. Bazin, M. Daudon, J. Phys. D Appl. Phys. 45 (2012) 383001.
[4] D. Bazin, J.-P. Haymann, E. Letavernier, J. Rode, M. Daudon, Presse
Med. 43 (2014) 135.
[5] H. Sarles, Gastroenterology 66 (1974) 604.
[6] H. Harada, M. Takeda, J. Tanaka, H. Miki, K. Ochi, I. Kimura, Gas-
troenterol. Jpn. 18 (1983) 530.
[7] A.L. Rodgers, Micron. Microsc. Acta 14 (1983) 219.
[8] E.W. Moore, H.J. Verine, J. Lab Clin. Med. 106 (1985) 611.
[9] A.L. Rodgers, M. Spector, Calcif Tissue Int. 39 (1986) 342.
[10] A. Noda, T. Takayama, Y. Ogawa, Y. Sugimoto, T. Shibata,
Y. Horiguchi, S. Kameya, Y. Nakanishi, Gastroenterol. Jpn. 21 (1986)
255.
[11] A.C. Schultz, P.B. Moore, P.J. Geevarhese, C.S. Pitchumoni, Dig. Dis.
Sci. 31 (1986) 476.[12] C.S. Pitchumoni, K.V. Viswanathan, P.J. Gee Varghese, P.A. Banks,
Pancreas 2 (1987) 152.
[13] Z.P. Jing, Zhonghua Wai Ke Za Zhi 28 (1990) 421.
[14] H. Tohda, Y. Tsuchiya, T. Kobayashi, H. Kishiro, T. Yanagisawa, J.
Electron. Microsc. (Tokyo) 43 (1994) 57.
[15] L. de Pablo-Galan, M.D. Lastra-Azpilicueta, Rev. Mex. Cienc. Geol.
14 (1997) 78.
[16] K.V.Narasimhulu, N.O. Gopal, J.L. Rao,N. Vijayalakshmi, S. Natarajan,
R. Surendran, V. Mohan, Biophys. Chem. 114 (2005) 137.
[17] E.K. Choi, G.A. Lehman, Korean J. Intern. Med. 27 (2012) 20.
[18] M. Daudon, C.A. Bader, P. Jungers, Scan. Microsc. 7 (1993) 1081.
[19] M. Daudon, R.J. Reveillaud, Nephrologie 5 (1984) 195.
[20] M. Daudon, L'Eurobiologiste XXVII 203 (1993) 35.
[21] A. Dessombz, P. Meria, D. Bazin, E. Foy, S. Rouziere, R. Weil,
M. Daudon, Prog. Urol. 21 (2011) 940.
[22] A. Dessombz, P. Meria, D. Bazin, M. Daudon, PLoS One 7 (2012)
e51691.
[23] T.C. Holme, M.M. Reis, A. Thompson, A. Robertson, D. Parham,
P. Hickman, P.E. Preece, Eur. Surg. Oncol. 19 (1993) 250.
[24] H.-K. Ea, C. Nguyen, D. Bazin, A. Bianchi, J. Guicheux, P. Reboul,
M. Daudon, F. Liote, Arthritis Rheum. 63 (2011) 10.
[25] C. Nguyen, H.-K. Ea, D. Bazin, M. Daudon, F. Liote, Arthritis Rheum.
62 (2010) 2829.
[26] C. Nguyen, H.K. Ea, D. Thiaudiere, S. Reguer, D. Hannouche,
M. Daudon, F. Liote, D. Bazin, J. Synchrotron Radiat. 18 (2011) 475.
[27] C. Nguyen, D. Bazin, M. Daudon, A. Chatron-Colliet, D. Hannouche,
A. Bianchi, D. Co^me, A. So, N. Busso, F. Liote, H.-K. Ea, Arthritis Res.
Ther. 15 (2013) R103.
[28] H.-K. Ea, V. Chobaz, C. Nguyen, S. Nasi, P. van Lent, M. Daudon,
A. Dessombz, D. Bazin, G. McCarthy, B. Jolles-Haeberli, A. Ives,
D. Van Linthoudt, A. So, F. Liote, N. Busso, PLoS One 8 (2013)
e57352.
[29] A.J. Skinner, J.P. Lafemina, H.J.F. Jansen, Am. Mineral. 79 (1994)
205.
[30] L. Kabalah-Amitai, B. Mayzel, Y. Kauffmann, A.N. Fitch, L. Bloch,
P.U.P.A. Gilbert, B. Pokroy, Science 340 (2013) 454.
[31] J.P.R. De Villiers, Am. Mineral. 56 (1971) 758.
[32] L. Multigner, M. Daudon, G. Montalto, A. de Caro, J.-P. Etienne,
H. Sarles, N. Engl. J. Med. 314 (1986) 248.
[33] N. Teich, J. M€ossner, Best Pract. Res. Clin. Gastroenterol. 22 (2008)
115.
[34] M.H. Derikx, J.P. Drenth, Best Pract. Res. Clin. Gastroenterol. 24
(2010) 251.
[35] R. Pfützer, E. Myers, S. Applebaum-Shapiro, R. Finch, I. Ellis,
J. Neoptolemos, J.A. Kant, D.C. Whitcomb, Gut 50 (2002) 271.
[36] R.H. Pfützer, M.M. Barmada, A.P. Brunskill, R. Finch, P.S. Hart,
J. Neoptolemos, W.F. Furey, D.C. Whitcomb, Gastroenterology 119
(2000) 615.
[37] J.M. Chen, C. Ferec, Annu. Rev. Genomics Hum. Genet. 10 (2009)
63.
[38] D. Bazin, M. Daudon, P. Chevallier, S. Rouziere, E. Elkaim,
D. Thiaudiere, B. Fayard, E. Foy, P.A. Albouy, G. Andre, G. Matzen,
E. Veron, Ann. Biol. Clin. 64 (2006) 125.
[39] M. Daudon, D. Bazin, J. Phys. Conf. Ser. 425 (2013) 022006.
[40] D. Bazin, M. Daudon, Ann. Biol. Clin., (in press).
[41] N. Quy-Dao, M. Daudon, Infrared and Raman Spectra of Calculi,
Elsevier, 1997.
[42] F. Brisset, M. Repoux (Eds.), Microscopie electronique a balayage et
microanalyse, EDP Sciences, 2008.
[43] M. Daudon, M.F. Protat, R.J. Reveillaud, Ann. Biol. Clin. 36 (1978)
475.
[44] H.A. Lowenstam, S. Weiner, On Biomineralization, Oxford Univer-
sity Press, 1989.
[45] R. Lakes, Nature 361 (1993) 511.
[46] J. Xiao, Y. Zhu, J. Juan, Q. Ruan, Y. Zheng, L. Cheng, L. Wang, F. Xu,
Mod. Phys. Lett. B 23 (2009) 3695.
[47] K. Benzerara, F. Skouri-Panet, J. Li, C. Ferard, M. Gugger, T. Laurent,
E. Couradeau, M. Ragon, J. Cosmidis, N. Menguy, I. Margaret-Oliver,
R. Tavera, P. Lopez-García, D. Moreira, Proc. Natl. Acad. Sci. USA
111 (2014) 10933.
[48] K. Benzerara, T.H. Yoon, T. Tyliszczak, B. Constantz, A.M. Spormann,
G.E. Brown Jr., Geobiology 2 (2004) 249.
[49] K. Benzerara, N. Menguy, P. Lopez-Garcia, T.-H. Yoon,
J. Kazmierczak, T. Tyliszczak, F. Guyot, G.E. Brown Jr., PNAS 103
(2006) 9440.
[50] K.B. Lee, S.B. Park, Y.N. Jang, S.W.J. Lee, J. Colloid Interface Sci. 355
(2011) 54.
[51] O. Cizer, C. Rodriguez-Navarro, E. Ruiz-Agudo, J. Elsen, D. Van
Gemert, K. Van Balen, J. Mat. Sci. 47 (2012) 6151.
J. Cros et al. / C. R. Chimie 19 (2016) 1642e1655 1655[52] K. Lee, W. Wagermaier, A. Masic, K.P. Kommareddy, M. Bennet,
I. Manjubala, S.-W. Lee, S.B. Park, H. C€olfen, P. Fratzl, Nat. Commun.
3 (2012) 725.
[53] J.H.E. Cartwright, A.G. Checa, J.D. Gale, D. Gebauer, C.I. Sainz-Díaz,
Angew. Chem. Int. Ed. 51 (2012) 11960.
[54] J. De Yoreo, Nat. Mater. 12 (2013) 284.
[55] B. Fritz, A. Clement, G. Montes-Hernandez, C. Noguera, Cryst. Eng.
Comm. 15 (2013) 3392.
[56] L.B. Gower, Chem. Rev. 108 (2008) 4551.
[57] M. Daudon, O. Traxer, P. Jungers, D. Bazin, AIP Conf. Proc. 900
(2007) 26.
[58] M. Daudon, P. Jungers, D. Bazin, New Eng. J. Med. 359 (2008) 100.
[59] M. Daudon, P. Jungers, D. Bazin, AIP Conf. Proc. 1049 (2008) 199.
[60] M. Daudon, D. Bazin, G. Andre, P. Jungers, A. Cousson, P. Chevallier,
E. Veron, G. Matzen, J. Appl. Crystallogr. 42 (2009) 109.
[61] X. Carpentier, M. Daudon, O. Traxer, P. Jungers, A. Mazouyes,
G. Matzen, E. Veron, D. Bazin, Urology 73 (2009) 968.
[62] D. Bazin, G. Andre, R. Weil, G. Matzen, E. Veron, X. Carpentier,
M. Daudon, Urology 79 (2012) 786.
[63] A. Dessombz, E. Letavernier, J.-P. Haymann, D. Bazin, M. Daudon., J.
Urol., (in press).
[64] T. Yong-Jin Han, J. Aizenberg, Chem. Mater. 20 (2008) 1064.
[65] Y. Politi, R.A. Metzler, M. Abrecht, B. Gilbert, F.H. Wilt, I. Sagi,
L. Addadi, S. Weiner, P.U.P.A. Gilbert, PNAS 105 (2008) 17362.
[66] Y. Levi-Kalisman, S. Raz, S. Weiner, L. Addadi, I. Sagi, Adv. Funct.
Mat. 12 (2002) 43.
[67] J. Ihli, W.C. Wong, E.H. Noel, Y.-Y. Kim, A.N. Kulak, H.K. Christenson,
M.J. Duer, F.C. Meldrum, Nat. Commun. 5 (2014) 3169.
[68] T. Ogino, T. Suzuki, K. Sawada, Geochim. Cosmochim. Acta 51
(1987) 2757.
[69] G. Behrens, L.T. Kuhn, R. Ubic, A.H. Heuer, Spectrosc. Lett. 28 (1995)
983.
[70] J. Dedek, Le Carbonate de Chaux, Librairie Universitaire Louvain,
1966.
[71] H. Teghidet, Etude de la cristallisation contro^lee de la calcite par
voie electrochimique. Effet desions etrangers au systeme calco-
carbonique sur la nucleation-croissance de la calcite, UPMC, 2012.
[72] N.H. de Leeuw, S.C. Parker, J. Phys. Chem. B 102 (1998) 2914.
[73] M. Van Meerssche, J. Feneau-Dupont, Introduction a la Cristallog-
raphie et ala Chimie Structurale, Vander, Louvain, Cesson, 1973.
[74] M. Ukrainczyk, J. Kontrec, D. Kralj, J. Colloid Interface Sci. 329
(2009) 89.
[75] E. Loste, R.M. Wilson, R. Seshadric, F.C. Meldrum, J. Cryst. Growth
254 (2003) 206.
[76] D.B. DeOliveira, R.A. Laursen, J. Am. Chem. Soc. 119 (1997) 10627.
[77] L. Breýeviû, A.E. Nielsen, J. Cryst. Growth 98 (1989) 504.
[78] S.S. Wang, A. Picker, H. C€olfen, A.-W. Xu, Angew. Chem. Int. Ed. 52
(2013) 6317.
[79] H. Sarles, Ann. Gastroenterol. Hepatol. 22 (1986) 37.
[80] A.M. De Caro, J.-J. Bonicel, P. Rouimi, D. De Caro, H. Sarles,
M. Rovery, Eur. J. Biochem. 168 (1987) 201.
[81] D. Giorgi, J.-P. Bernard, S. Rouquier, J. Iovanna, H. Sarles,
J.C. Dagorn, Clin. Invest. 84 (1989) 100.
[82] M. Provensal-Cheylan, A. Mariani, J.-P. Bemard, H. Sarles, P. Dupuy,
Pancreas 4 (1989) 680.
[83] L. Patard, J.Y. Lallemand, V. Stoven, J.O.P. 4 (2003) 92.[84] J.M. Verdier, B. Dussol, P. Casanova, M. Daudon, P. Dupuy,
P. Berthezene, R. Boistelle, Y. Berland, J.C. Dagorn, Eur. J. Clin.
Invest. 22 (1992) 469.
[85] D. Bazin, M. Daudon, G. Andre, R. Weil, E. Veron, G. Matzen, J. Appl.
Crystallogr. 47 (2014) 719.
[86] M.L. Steer, I.Waxman, S. Freedman, N. Engl. J.Med. 332 (1995) 1482.
[87] E.V. Loftus Jr., B.A. Olivares-Pakzad, K.P. Batts, M.C. Adkins,
D.H. Stephens, M.G. Sarr, E.P. DiMagno, Gastroenterology 110
(1996) 1909.
[88] A. Campisi, G. Brancatelli, M.-P. Vullierme, P. Levy, P. Ruzniewski,
V. Vilgrain, Clin. Radiol. 64 (2009) 903.
[89] T.B. Morse, AstroPhys. J. 26 (1907) 225.
[90] H.H. Adler, P.F. Kerr, Am. Mineral. 47 (1962) 700.
[91] C.E. Weir, E.R. Lippincott, J. Res. NBS A 65A (1961) 173.
[92] G. Hertzberg, Molecular Spectra and Molecular Structure, in:
Infrared and Raman Spectra of Polyatomic Molecules, seventh ed.,
vol. II, D. Van Nostrand Co., New York, N.Y., 1956, p. 178.
[93] D.F. Hornig, J. Chem. Phys. 16 (1948) 1063.
[94] R.S. Halford, J. Chem. Phys. 14 (1946) 8.
[95] S. Gunasekaran, G. Anbalagan, S. Pandi, J. Raman Spectrosc. 37
(2006) 892.
[96] N.V. Vagenas, A. Gatsouli, C.G. Kontoyannis, Talanta 59 (2003) 831.
[97] D. Lou, F. Sun, L. Li, Chin. Opt. Lett. 05 (2007) 370.
[98] J.A. Gadsden (Ed.), Infrared Spectra of Minerals and Related Inor-
ganic Compounds, Butterworths, New York, 1975.
[99] D.R. Taylor, R.S. Crowther, J.C. Cozart, P. Sharrock, J. Wu,
R.D. Soloway, Hepatology 22 (1995) 488.
[100] C. Wang, J. Zhao, X. Zhao, H. Bala, Z. Wang, Powder Technol. 163
(2006), 134.9090.
[101] K.H.Hellwege,W. Lesch,M. Plihal, G. Schaack, Z. Phys. 232 (1970) 61.
[102] P. Gillet, P. Mcmillan, J. Schott, J. Badro, A. Grzechnik, Geochim.
Cosmochim. Acta 60 (1996) 3471.
[103] G. Müller, W. W€asche, U. Bindig, K. Liebold, Laser Phys. 9 (1999)
348.
[104] Y.-J. Chen, Y.-D. Cheng, H.-Y. Liu, P.-Y. Lin, C.-S. Wang, Chang Gung
Med. J. 29 (2006) 518.
[105] Z. Movasaghi, S. Rehman, I. Ur Rehman, Appl. Spectrosc. Rev. 43
(2008) 134.
[106] F. Le Naour, M.-P. Bralet, D. Debois, C. Sandt, C. Guettier, P. Dumas,
A. Brunelle, O. Laprevote, PLoS One 4 (2009) e7408.
[107] P. Bassan, A. Sachdeva, A. Kohler, C. Hughes, A. Henderson, J. Boyle,
J.H. Shanks, M. Brown, N.W. Clarke, P. Gardner, Analyst 137 (2012)
1370.
[108] L.M. Miller, P. Dumas, Curr. Opin. Struct. Biol. 20 (2010) 649.
[109] J. Kong, S. Yu, Acta Biochim. Biophys. Sin. 39 (2007) 549.
[110] A. Grunenwald, C. Keyser, A.M. Sautereau, E. Crubezy, B. Ludes,
C. Drouet, J. Archaeol. Sci. 49 (2014) 134.
[111] J.R. Schoonover, R. Marx, W.R. Nichols, Vib. Spectrosc. 35 (2004)
239.
[112] M. De Luca, W. Terouzi, G. Ioele, F. Kzaiber, A. Oussama, F. Oliverio,
R. Tauler, G. Ragno, Food Chem. 124 (2011) 1113.
[113] P. Layer, H. Goebell, Schweiz Med. Wochenschr. 119 (1989) 1655.
[114] B. Carnaille, C. Oudar, F. Pattou, F. Combemale, J. Rocha, C. Proye,
Aust. N. Z. J. Surg. 68 (2) (1998 Feb) 117e119.
[115] E. Hollande, J.-H. Levrat di Donato, M. Fanjul, C. Palevody,
M. Daumas, J. Puech, G. Ratovo, Biol. Cell. 69 (1990) 191.
